Persistence of neutrophil hypersegmentation during recovery from megaloblastic granulopoiesis.

We studied the rate of disappearance of neutrophil hypersegmentation in 23 patients with megaloblastic anemia during therapy with vitamin B12 and folic acid. In 14 patients with uncomplicated megaloblastic anemia, the neutrophil lobe average began to fall towards normal 11.4 +/- 0.3 (SEM) days after treatment was begun and became normal by 13.9 +/- 0.6 days. In nine patients with associated inflammatory disorders, the lobe average returned to normal more rapidly. In six initially neutropenic patients, a five-fold increase in total granulocyte count occurred by the eighth day and a seven-fold increment in the total number of circulating hypersegmented neutrophils. Granulocyte folate concentrations in five folate-deficient patients rose to normal levels within 4 to 7 days of starting therapy. Hypersegmentation thus persists for many days after correction of neutropenia and restoration of normal granulocyte folate levels have occurred. We conclude that cobalamin and folate are needed at two different steps in granulopoiesis.
AuthorsB J Nath, J Lindenbaum
JournalAnnals of internal medicine (Ann Intern Med) Vol. 90 Issue 5 Pg. 757-60 (May 1979) ISSN: 0003-4819 [Print] UNITED STATES
PMID434675 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Folic Acid
  • Vitamin B 12
  • Anemia, Macrocytic (drug therapy)
  • Anemia, Megaloblastic (blood, drug therapy, etiology)
  • Blood Cell Count
  • Folic Acid (blood, therapeutic use)
  • Granulocytes (metabolism)
  • Humans
  • Neutrophils (metabolism, pathology)
  • Prospective Studies
  • Reticulocytes
  • Vitamin B 12 (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: